Mild emphysema generally has a better prognosis with active treatment.
Emphysema is a pathologically irreversible condition in which the elasticity of the airways of the distal fine bronchioles of the lungs, including fine bronchioles, alveoli, and alveolar ducts, decreases, resulting in persistent abnormal excess air content, hyperinflation, and increased lung volume, or accompanied by destruction of the airway walls.
Although it cannot be effectively reversed clinically, active symptomatic treatment of early mild emphysema can still effectively control the progression of the disease, alleviate the symptoms of mild emphysema, and reduce the probability of acute exacerbation.
It is recommended that patients seek medical advice in a timely manner to prevent further exacerbation of the disease by controlling lifestyle habits such as smoking cessation, aerobic exercise, and the use of home oxygen therapy. Meanwhile, medication is used under the guidance of a doctor. Commonly used medications include budesonide aerosol, terbutaline nebulizer, and so on. The prognosis is generally good.
Patients with mild emphysema are advised to seek prompt medical attention and active treatment under the guidance of a physician. The above medications should be used under the guidance of a physician.